Explore the Agenda
Pre-Conference Day
Tuesday, 15th September
Day One
Wednesday, 16th September
Day Two
Thursday, 17th September
8:00 am Registration & Coffee
8:50 am Chair’s Opening Remarks
Measuring the True Impact of Patient Engagement Across the Entire Product Lifecycle
9:00 am Measurement from the Chief Patient Officer’s Perspective: Creating Organisational Frameworks that Combine Business Objectives with Unmet Patient Needs
- Building end-to-end patient engagement strategies that integrate business priorities with unmet patient needs
- Measuring dual impact by tracking both business-value and patient-value outcomes
- Demonstrating results effectively to internal leadership, regulators, and external stakeholders
9:30 am The Quantitative Side of Patient-Centric Early Research
- Valuing patient engagement in early research to explore uncover and neglected key symptoms
- Converting qualitative patient input into quantitative metrics and actionable KPI symptoms
- Highlighting approaches that ensure patient input drives decisions long before clinical development
10:00 am How to Define the Impact of Patient Engagement in Early Research: A Target Value Profile Approach
- Defining patient‑driven Target Value Profiles (TVPs) to set prospective expectations for value in early and preclinical research
- Applying qualitative and quantitative insights from patient advisory panels to inform early research decision‑making
- Translating Target Product Profile (TPP) characteristics to value attributes and impact areas under Target Value Profile (TVP)
- Embedding patient‑defined value criteria into forward‑looking KPIs to strengthen long‑term R&D outcomes
10:30 am Morning Break & Speed Networking
Join our speed networking session tailored for Patient Engagement professionals, like yourselves, to connect with fellow industry peers to facilitate rapid yet meaningful exchanges of insights and expertise. Elevate your networking experience during this session designed for impactful connections within the space
11:30 am From Insight to Impact: Integrating Feasibility With Patient & Site Engagement to Measure What Truly Drives Trial Success
- Feasibility as the earliest measure of engagement impact
- Moving from activity metric to outcome driven KPIs
- Creating a shared measurement framework across functions
12:00 pm From Reporting to Real Impact: Measuring Patient Engagement in the Evolving ESG Landscape
- An overview of the latest CSRD changes and how they open the door to stronger, more structured PE reporting
- Insight into how other global ESG frameworks – including the UN Sustainable Development Goals (SDGs), Social Return on Investment (SROI), and others – are being leveraged to assess and report on engagement with patients and communities
- A first look at PFMD’s third annual ESG landscaping analysis, offering real-world examples and trends across the industry
12:30 pm Measuring the Impact of Patient Engagement: Building Evaluation Frameworks that Drive Continuous Improvement
- Assessing the impact of patient engagement across both external patient initiatives and internal stakeholder engagement
- Navigating operational, compliance, and organisational challenges when collecting meaningful feedback and outcomes data
- Leveraging benchmarking and evaluation insights to strengthen future patient engagement strategies and demonstrate organisational value
- Key lessons learned from implementing evaluation processes and governance structures within a large organisation
1:00 pm Lunch & Networking
2:00 pm From Corporate Purpose to Patient Impact: A Company‑Wide Framework for Patient Engagement
- Designing a systematic, company‑wide patient engagement framework to embed the patient voice across R&D, access and commercialization
- Moving from activity‑based engagement to value‑ and impact‑driven patient involvement across the asset lifecycle
- Linking patient engagement outcomes to corporate purpose, culture and ESG commitments, beyond individual initiatives
- Measuring the impact of patient engagement at different stages of the asset lifecycle, from clinical development to market access and support programmes
Embedding Patient Engagement into Strategy: Frameworks to Prove Value Across Teams
2:30 pm Fireside Chat: What Does the C-Suite Need to See to Champion Patient Engagement?
- Identifying engagement KPIs that influence C-suite decisions including time-to-market, recruitment efficiency, and portfolio value
- Discussing how to identify relevant KPIs that capture impact across drug discovery lifecycle and across differing therapy areas
- Navigating how perceptions of impact and value vary across functions
3:00 pm Network & Learn Break: Measurement in Practice
This interactive break is your opportunity to explore how teams are approaching patient engagement measurement in practice. Discover real-world examples, frameworks, and work in progress, and engage directly with peers to exchange ideas and experiences. Use this time to discuss how others are defining KPIs, capturing impact, and building credible evidence across the lifecycle.
If you’d like to share an approach, framework, or piece of work, please contact info@hansonwade.com
3:30 pm Moving Beyond Words to Build a Multi-Metric Framework That Embeds Patient Engagement into Drug Development
As more life sciences organisations formalise their patient engagement commitments, the real challenge lies in turning highlevel intentions into structured, measurable action. This interactive session, led by PFMD, combines hands-on exercises with insights from a global review of industry charters to help you build an engagement framework grounded in accountability and real-world impact.
You’ll work through diverse scenarios – across indications, modalities, and company scales – to design an adaptable, multi-metric model you can bring back to your team.
Key Takeaways:
- Identify fit-for-purpose metrics that reflect your organisation’s priorities and the needs of diverse patient communities
- Learn how industry leaders are embedding metrics into patient engagement charters to track progress and drive meaningful change
- Explore PFMD’s cross-sector efforts to standardise measurement and design frameworks that evolve with your organisation
- Develop a stakeholder-aligned strategy for communicating value, accountability, and success
- Leave with a practical, scalable template to support consistent measurement and improvement across the product lifecycle
By the end, you’ll have a flexible, actionable framework to bring back to your team – helping to standardise measurement and clearly demonstrate the impact of patient engagement across your projects.